Glecaprevir is a protease inhibitor within the hepatitis C virus NS3/4A class, utilized in combination therapies to treat chronic hepatitis C infection. Pharmaceutical laboratories require precise reference… Read more
![Chemical structure of (1R,2R)-1-Amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1360828-80-3-1R2R-1-Amino-2-difluoromethyl-N-1-methylcyclopropylsulfonylcyclopropanecarboxamide-Hydrochloride.png&w=3840&q=75)

![Chemical structure of 1-[3-(Dimethylamino)propyl]-3-ethylurea](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F32897-26-0-1-3-Dimethylaminopropyl-3-ethylurea.png&w=3840&q=75)




Glecaprevir is a protease inhibitor within the hepatitis C virus NS3/4A class, utilized in combination therapies to treat chronic hepatitis C infection. Pharmaceutical laboratories require precise reference standards for this active pharmaceutical ingredient to support rigorous quality control and regulatory compliance. This category includes comprehensive reference materials, such as synthetic impurities and degradation products, which are essential for impurity profiling and method validation during drug development. Additionally, stable isotope labelled compounds are provided to serve as critical internal standards for accurate quantitative analysis in mass spectrometry and other analytical techniques. By offering a range of these specialized compounds, including key intermediates and related derivatives, this catalogue assists researchers in ensuring the consistency, safety, and efficacy of pharmaceutical formulations containing this antiviral agent throughout the manufacturing and testing lifecycle.